Inappropriate leukocyte activation in venous disease

The Vein Book

Volumn , Issue , 2007, Pages 57-65

  Smith, Philip Coleridge ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77949386133     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369515-4/50009-0     Document Type: Chapter

References (49)

1. Moffatt CJ, Franks PJ, Doherty DC, Martin R, Blewett R, Ross F. Prevalence of leg ulceration in a London population. QJM. 1904, 97:431-437.
2. Evans CJ, Fowkes FG, Ruckley CV, Lee AJ. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study. J Epidemiol Community Health. 1999, 53:149-153.
3. Callam MJ, Ruckley CV, Harper DR, Dale JJ. Chronic ulceration of the leg: Extent of the problem and provision of care. BMJ. 1985, 290:1855-1856.
4. Baker SR, Stacey MC, Singh G, Hoskin SE, et al. Aetiology of chronic leg ulcers. Eur J Vasc Surg. 1992, 6:245-251.
5. Nelzén O, Bergqvist D, Lindhagen A, Hallböök T. Chronic leg ulcers: An underestimated problem in primary health care among elderly patients. J Epidemiol Community Health. 1991, 45:184-187.
6. Nicolaides AN, Zukowski A, Lewis R, Kyprianou P, Malouf GM Venous pressure measurements in venous problems. Surgery of the Veins 1985, 111-118. Grune and Stratton Inc., Orlando. J.J. Bergan, J.S.T. Yao (Eds.).
7. Dodd H, Cockett FB The pathology and surgery of the veins of the lower limb 1976, Churchill Livingstone, Edinburgh.
8. Hoare MC, Nicolaides AN, Miles CR, Shull K, Jury RP, Needham T, Dudley HAF. The role of primary varicose veins in venous ulceration. Surgery. 1982, 92:450-453.
9. Browse NL, Burnand KG. The cause of venous ulceration. Lancet. 1982, ii:243-245.
10. Browse NL, Gray L, Jarrett PEM, Morland M. Blood and vein-wall fibrinolytic activity in health and vascular disease. Br Med J. 1977, i:478-481.
11. Cheatle TR, McMullin GM, Farrah J, Coleridge Smith PD, Scurr JH. Three tests of microcirculatory function in the evaluation of treatment for chronic venous insufficiency. Phlebology. 1990, 5:165-172.
12. Thomas PRS, Nash GB, Dormandy JA. White cell accumulation in the dependent legs of patients with venous hypertension: A possible mech-anism for trophic changes in the skin. Br Med J. 1988, 296:1693-1695.
13. Braide M, Amundson B, Chien S, Bagge U. Quantitative studies of leucocytes on the vascular resistance in a skeletal muscle preparation. Microvasc Res. 1984, 27:331-352.
14. Engler RL, Dahlgren MD, Peterson MA, Dobbs A, Schmid-Schoenbein GW. Accumulation of polymorphonuclear leucocytes during three hour myocardial ischemia. Am J Physiol. 1986, 251:H93-H100.
15. Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork MA, Lucchesi BR. Reduction of the extent of ischemic myocardial injury by neutro-phil depletion in the dog. Circulation. 1983, 67:1016-1023.
16. Wilson JW. Leucocyte sequestration and morphologic augmentation in the pulmonary network following haemorrhagic shock and related forms of stress. Adv Microcirc. 1972, 4:197-232.
17. Linas SL, Shanley PF, Whittenburg D, Berger E, Repine JE. Neutro-phils accentuate ischemia-reperfusion injury in isolated perfused rat kidneys. Am J Physiol. 1988, 255:F728-F735.
18. Yamakawa T, Suguyama I, Niimi H. Behaviour of white blood cells in microcirculation of the cat brain cortex during hemorrhagic shock. Intravital microscopic study. Int J Microcirc: Clin Exp. 1984, 3:554.
19. Braide M, Blixt A, Bagge U. Leukocyte effects on the vascular resis-tance and glomerular filtration of the isolated rat kidney at normal and low flow rates. Circulatory Shock. 1986, 20:71-80.
20. Weissman G, Smolen JE, Korchak HM. Release of inflammatory mediators from stimulated neutrophils. N Engl J Med. 1980, 303:27-34.
21. Babior BM. Oxidants from phagocytes: Agents of defense and destruc-tion. Blood. 1984, 64:959-966.
22. Coleridge Smith PD, Thomas P, Scurr JH, Dormandy JA. Causes of venous ulceration: A new hypothesis. Br Med J. 1988, 296:1726-1727.
23. Shields DA, Andaz S, Abeysinghe RD, Porter JB, Scurr JH, Coleridge Smith PD. Neutrophil activation in experimental ambulatory venous hypertension. Phlebology. 1994, 9:119-124.
24. Shields D, Andaz SK, Timothy-Antoine CA, Scurr JH, Porter JB CD1 1b/CD1 8 as a marker of neutrophil adhesion in experimental ambu- latory venous hypertension. Phlebology 1995, 108-109. Suppl. 1. D. Negus, G. Jantet, P.D. Coleridge Smith (Eds.).
25. Saharay M, Shields DA, Porter JB, Scurr JH, Coleridge Smith PD. Leukocyte activity in the microcirculation of the leg in patients with chronic venous disease. J Vasc Surg. 1997, 26:265-273.
26. Shields DA, Andaz S, Sarin S, Scurr JH, Coleridge Smith PD. Neutro-phil activation in experimental venous hypertension. Phlebologie. 1993, 46:687-689.
27. Shields DA, Andaz S, Abeysinghe RD, Porter JB, Scurr JH, Coleridge Smith PD. Plasma lactoferrin as a marker of white cell degranulation in venous disease. Phlebology. 1994, 9:55-58.
28. Shields DA, Andaz SK, Sarin S, Scurr JH, Coleridge Smith PD. Plasma elastase in venous disease. Br J Surg. 1994, 81:1496-1499.
29. Shields D, Saharay M, Timothy-Antoine CA, Porter JB, Scurr JH Neutrophil CD1 1b expression in patients with venous disease. Phlebology 1995, 108-109. Suppl. 1. D. Negus, G. Jantet, S.P.D. Coleridge (Eds.).
30. Scott HJ, McMullin GM, Coleridge Smith PD, Scurr JH. A histologi-cal study into white blood cells and their association with lipoderma-tosclerosis and ulceration. Br J Surg. 1990, 78:210-211.
31. Wilkinson LS, Bunker C, Edwards JC, Scurr JH, Coleridge Smith PD. Leukocytes: Their role in the etiopathogenesis of skin damage in venous disease. J Vasc Surg. 1993, 17:669-675.
32. Burnand KG, Whimster I, Naidoo A, Browse NL. Pericapillary fibrin in the ulcer-bearing skin of the leg: The cause of lipodermatosclerosis and venous ulceration. Br Med J. 1982, 285:1071-1072.
33. Haselbach P, Vollenweider U, Moneta G, Bollinger A. Microangiopa-thy in severe chronic venous insufficiency evaluated by fluorescence video-microscopy. Phlebology. 1986, 1:159-169.
34. Howlader MH, Coleridge Smith PD. Microangiopathy in chronic venous insufficiency: Quantitative assessment by capillary micros-copy. Eur J Vasc Endovasc Surg. 1903, 26:325-331.
35. Veraart JC, Verhaegh ME, Neumann HA, Hulsmans RF, Arends JW. Adhesion molecule expression in venous leg ulcers. Vasa. 1993, 22:213-218.
36. Herrick SE, Sloan P, McGurk M, Freak L, McCollum CN, Ferguson MW. Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers. Am J Pathol. 1992, 141:1085-1095.
37. Scott HJ, McMullin GM, Coleridge Smith PD, Scurr JH. A histologi-cal study into white blood cells and their association with lipoderma-tosclerosis and ulceration. Br J Surg. 1990, 78:210-211.
38. Falanga V, Kruskal J, Franks JJ. Fibrin-and fibrinogen-related antigens in patients with venous disease and venous ulceration. Arch Dermatol. 1991, 127:75-78.
39. Saharay M, Shields DA, Georgiannos SN, Porter JB, Scurr JH, Coleridge Smith PD. Endothelial activation in patients with chronic venous disease. Eur J Vasc Endovasc Surg. 1998, 15:342-349.
40. Pardoe HD The expression of angiogenic growth factors in the skin of patients with chronic venous disease of the lower limb. MSc Thesis 1996, 1-61. September, University College London.
41. Pappas PJ, You R, Rameshwar P, Gorti R, DeFouw DO, Phillips CK, et al. Dermal tissue fibrosis in patients with chronic venous insuffi-ciency is associated with increased transforming growth factor-beta1 gene expression and protei. J Vasc Surg. 1999, 30:1129-1145.
42. Degiorgio-Miller AM, Treharne LJ, McAnulty RJ, Coleridge Smith PD, Laurent GJ, Herrick SE. Procollagen type I gene expression and cell proliferation are increased lipodermatosclerosis. Br J Dermatol. 1905, 152:242-249.
43. Higley HR, Ksander GA, Gerhardt CO, Falanga V. Extravasation of macromolecules and possible trapping of transforming growth factor-beta in venous ulceration. Br J Dermatol. 1995, 132:79-85.
44. Falanga V, Eaglstein WH. The "trap" hypothesis of venous ulceration. Lancet. 1993, 341:1006-1008.
45. Sullivan GW, Carper HT, Novick WJ, Mandell GL. Inhibition of the inflammatory action of interleukin-1 and tumour necrosis factor (alpha) on neutrophil function by pentoxifylline Infect. Immunol. 1988, 56:1722-1729.
46. Jull AB, Waters J, Arroll B. Pentoxifylline for treating venous leg ulcers. Cochrane Database Syst Rev. 1902, (1):CD001733.
47. Milio G, Mina C, Cospite V, Almasio PL, Novo S. Efficacy of the treatment with prostaglandin E-1 in venous ulcers of the lower limbs. J Vasc Surg. 1905, 42:304-308.
48. Laurent R, Gilly R, Frileux C. Clinical evaluation of a venotropic drug in man. Example of Daflon 500 mg. Int Angiol. 1988, 7(2 Suppl):39-43.
49. Coleridge-Smith P, Lok C, Ramelet AA. Venous leg ulcer: A meta-analysis of adjunctive therapy with micronized purified flavonoid frac-tion. Eur J Vasc Endovasc Surg. 1905, 30:198-208.